Driving the future of medicines manufacturing

From digital chemistry to advanced CMC solutions, we turn cutting-edge science into real-world impact.

CMAC is at the forefront of transforming how medicines are made. We combine world-class research with industry collaboration to deliver practical, scalable solutions across digital chemistry, manufacturing and controls (CMC).

Our research ecosystem, anchored by our CMC DataFactory® and specialist streams such as CCS, MCS+, BPCS and QbDD enables rapid translation of science into industrial-scale processes.

We offer multiple engagement pathways, including staff exchanges, placements, expert-led training and pre-competitive programmes to foster co-creation and accelerate technology adoption.

With a proven track record of partnerships with CDMOs, innovation centres, and global pharma, CMAC is shaping the UK’s innovation landscape.

Our Strategy

Our strategic collaborators

We work with global industrial partners to co-create and translate world-leading research into impactful, industry-ready technologies across a range of Technology Readiness Levels.

Through this partnership model, we accelerate the digitalisation of Chemistry, Manufacturing and Control (CMC) processes, enabling the adoption of advanced pharmaceutical manufacturing solutions.

Our partnerships go beyond our industry membership. We offer many routes to collaboration and work closely with academic institutions, regulatory bodies, government agencies and other industry organisations to drive innovation and shape the future of medicines.

If you’d like to work with CMAC, reach out to our team for a discussion about how we can support your goals.

  • Together with our Tier One global pharma partners, we are delivering our strategy through a portfolio of collaborative, precompetitive research, translation and skills projects, driving innovation and impact across the medicines manufacturing landscape.

  • We collaborate with leading CDMOs and tech vendors to accelerate CMC innovation, combining expertise in crystallisation, PAT, and digitisation with CMAC’s facilities to deliver integrated, efficient solutions for advanced medicines manufacturing.

  • Our Tier Two community is a dynamic network spanning digital technologies, data analytics, advanced manufacturing, consultancy, and specialised CROs, each bringing unique expertise to support shared goals through formal collaboration.

  • Our academic partners are leading universities and research institutions that work with us to advance cutting-edge research, whilst sharing expertise and developing solutions that shape the future of medicines.

  • Industry, third sector, government, regulators

Our Partners
Contact us

Translation to Industry

Our Translation to Industry portfolio demonstrates our commitment to turning cutting-edge academic research into practical, scalable solutions for pharmaceutical manufacturing. We bridge the gap between theory and real-world application, ensuring discoveries deliver value and impact for our industry partners.

Through our portfolio, companies have access to opportunities, including:

  • TRL-based development and progression, including commercialisation via our CMC DataFactories® and National Facility

  • Staff exchanges i.e. secondments for knowledge exchange and PhD placements to build future talent

  • Tailored 1:1 project partnerships and pre-competitive, industry-funded programmes to drive innovation and shared success

  • CMAC SkillsFactory in-person and online training for workforce development

Make it happen
A variety of blister packs of pills in different colors and shapes scattered on a surface.

Other Engagement Routes

  • A scientist wearing blue gloves and protective glasses working with a large scientific instrument, likely in a laboratory setting.

    CMAC National Facility

    From development to commercial manufacturing, CMAC’s national facility helps accelerate innovation. Through integrated services and partnerships, our experts provide support and technologies for seamless solutions from concept to commercialisation.

    Get started
  • A scientist working on a laptop in a laboratory with robotic arms and scientific equipment.

    Collaborative Opportunities

    We partner with organisations on funding awards, Knowledge Transfer Partnerships and strategic initiatives that drive innovation and impact.

    Coming soon
  • PhD@Work

    PhD@Work

    Advance your career and earn a PhD through CMAC’s PhD@Work programme, where flexible study meets real-world impact.

    Explore more

“CMAC has a unique way of working that’s been really successful. They listen to what the industry needs and align with industrial strategies. It very much feels like a partnership.”

— Jon-Paul Sherlock, AstraZeneca

A woman holding a pill in front of a microscope with a digital microchip overlay, with images of powder and tablets connected to the microchip.

Making an Impact

Icon of a person giving a presentation or speech in front of an audience, with a large screen or board behind them.

Paving the Way for Future Leaders

Outline icon of a person wearing a graduation cap and gown.

Talent Pipeline

Icon of four arrows branching out in different directions

Creating Opportunities Across Pharma

Flowchart diagram with various shapes connected by lines, depicting a process or system.

Translating Research & Technologies to Industry

Illustration of five people sitting around a table with chat bubbles, representing a discussion or meeting.

Consortium of Experts

Icon of a lightbulb with a brain inside, symbolizing ideas and creativity.

Pre-Competitive Collaboration

Explore how CMAC is driving change and making a meaningful impact, one innovation at a time.

Get in touch

Gray circle with a white envelope icon in the center, indicating email or messaging.

Interested in working with CMAC? Connect with our industry team to explore how we collaborate across the medicines manufacturing landscape.

Contact us